{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:40Z","timestamp":1786982140496,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s11916-023-01105-6","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T05:02:56Z","timestamp":1680757376000},"page":"89-97","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Use of Oxytocin for the Treatment of Opioid Use Disorder"],"prefix":"10.1007","volume":"27","author":[{"given":"Amber N.","family":"Edinoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saveen","family":"Sall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauryn G.","family":"Honore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross M.","family":"Dies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa R.","family":"Zaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Kataria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse M.","family":"Cornett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Murnane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"issue":"10 Suppl","key":"1105_CR1","first-page":"S200","volume":"24","author":"NE Hagemeier","year":"2018","unstructured":"Hagemeier NE. Introduction to the opioid epidemic: the economic burden on the healthcare system and impact on quality of life. Am J Manag Care. 2018;24(10 Suppl):S200\u20136.","journal-title":"Am J Manag Care"},{"issue":"3","key":"1105_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11916-018-0670-z","volume":"22","author":"N Vadivelu","year":"2018","unstructured":"Vadivelu N, Kai AM, Kodumudi V, Sramcik J, Kaye AD. The opioid crisis: a comprehensive overview. Curr Pain Headache Rep. 2018;22(3):16. https:\/\/doi.org\/10.1007\/s11916-018-0670-z.","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"1105_CR3","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC202201180","volume":"175","author":"JL Taylor","year":"2022","unstructured":"Taylor JL, Samet JH. Opioid use disorder. Ann Intern Med. 2022;175(1):ITC1\u201316. https:\/\/doi.org\/10.7326\/AITC202201180.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1105_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","volume":"6","author":"J Strang","year":"2020","unstructured":"Strang J, et al. Opioid use disorder. Nat Rev Dis Primer. 2020;6(1):3. https:\/\/doi.org\/10.1038\/s41572-019-0137-5.","journal-title":"Nat Rev Dis Primer"},{"issue":"2","key":"1105_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/neurolint14020035","volume":"14","author":"AN Edinoff","year":"2022","unstructured":"Edinoff AN, et al. Alternative options for complex, recurrent pain states using cannabinoids, psilocybin, and ketamine: a narrative review of clinical evidence. Neurol Int. 2022;14(2):423\u201336. https:\/\/doi.org\/10.3390\/neurolint14020035.","journal-title":"Neurol Int"},{"issue":"1","key":"1105_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/neurolint14010004","volume":"14","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, et al. Naltrexone implant for opioid use disorder. Neurol Int. 2021;14(1):49\u201361. https:\/\/doi.org\/10.3390\/neurolint14010004.","journal-title":"Neurol Int"},{"key":"1105_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pbb.2013.07.015","volume":"119","author":"M Tops","year":"2014","unstructured":"Tops M, Koole SL, IJzerman H, Buisman-Pijlman FTA. Why social attachment and oxytocin protect against addiction and stress: Insights from the dynamics between ventral and dorsal corticostriatal systems. Pharmacol Biochem Behav. 2014;119:39\u201348. https:\/\/doi.org\/10.1016\/j.pbb.2013.07.015.","journal-title":"Pharmacol Biochem Behav"},{"issue":"13","key":"1105_CR8","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","volume":"284","author":"AT McLellan","year":"2000","unstructured":"McLellan AT, Lewis DC, O\u2019Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284(13):1689\u201395. https:\/\/doi.org\/10.1001\/jama.284.13.1689.","journal-title":"JAMA"},{"issue":"17","key":"1105_CR9","doi-asserted-by":"publisher","first-page":"E4294","DOI":"10.3390\/ijms20174294","volume":"20","author":"S-C Wang","year":"2019","unstructured":"Wang S-C, Chen Y-C, Lee C-H, Cheng C-M. Opioid addiction, genetic susceptibility, and medical treatments: a review. Int J Mol Sci. 2019;20(17):E4294. https:\/\/doi.org\/10.3390\/ijms20174294.","journal-title":"Int J Mol Sci"},{"key":"1105_CR10","doi-asserted-by":"publisher","unstructured":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Lond Engl. 2017;390(10100):1211\u20131259.\u00a0https:\/\/doi.org\/10.1016\/S0140-6736(17)32154-2.","DOI":"10.1016\/S0140-6736(17)32154-2"},{"key":"1105_CR11","first-page":"1","volume":"329","author":"H Hedegaard","year":"2018","unstructured":"Hedegaard H, Mini\u00f1o AM, Warner M. Drug overdose deaths in the United States, 1999\u20132017. NCHS Data Brief. 2018;329:1\u20138.","journal-title":"NCHS Data Brief"},{"key":"1105_CR12","doi-asserted-by":"publisher","unstructured":"Daley DC, Smith E, Balogh D, Toscaloni J. Forgotten but not gone: the impact of the opioid epidemic and other substance use disorders on families and children. Commonwealth. 2018;20. https:\/\/doi.org\/10.15367\/com.v20i2-3.189.","DOI":"10.15367\/com.v20i2-3.189"},{"issue":"9","key":"1105_CR13","first-page":"1","volume":"67","author":"H Hedegaard","year":"2018","unstructured":"Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs most frequently involved in drug overdose deaths: United States, 2011\u20132016. Natl Vital Stat Rep Cent Dis Control Prev Natl Cent Health Stat Natl Vital Stat Syst. 2018;67(9):1\u201314.","journal-title":"Natl Vital Stat Rep Cent Dis Control Prev Natl Cent Health Stat Natl Vital Stat Syst"},{"issue":"4","key":"1105_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s40140-020-00420-7","volume":"10","author":"LM Lueptow","year":"2020","unstructured":"Lueptow LM, Shashkova EC, Miller MG, Evans CJ, Cahill CM. Insights into the neurobiology of craving in opioid use disorder. Curr Anesthesiol Rep. 2020;10(4):378\u201387. https:\/\/doi.org\/10.1007\/s40140-020-00420-7.","journal-title":"Curr Anesthesiol Rep"},{"issue":"3","key":"1105_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-p","volume":"18","author":"TE Robinson","year":"1993","unstructured":"Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev. 1993;18(3):247\u201391. https:\/\/doi.org\/10.1016\/0165-0173(93)90013-p.","journal-title":"Brain Res Brain Res Rev"},{"issue":"8","key":"1105_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1037\/amp0000059","volume":"71","author":"KC Berridge","year":"2016","unstructured":"Berridge KC, Robinson TE. Liking, wanting, and the incentive-sensitization theory of addiction. Am Psychol. 2016;71(8):670\u20139. https:\/\/doi.org\/10.1037\/amp0000059.","journal-title":"Am Psychol"},{"issue":"1","key":"1105_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biopsych.2019.05.023","volume":"87","author":"GF Koob","year":"2020","unstructured":"Koob GF. Neurobiology of opioid addiction: opponent process, hyperkatifeia, and negative reinforcement. Biol Psychiatry. 2020;87(1):44\u201353. https:\/\/doi.org\/10.1016\/j.biopsych.2019.05.023.","journal-title":"Biol Psychiatry"},{"issue":"6","key":"1105_CR18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40263-019-00637-z","volume":"33","author":"M Shulman","year":"2019","unstructured":"Shulman M, Wai JM, Nunes EV. Buprenorphine treatment for opioid use disorder: an overview. CNS Drugs. 2019;33(6):567\u201380. https:\/\/doi.org\/10.1007\/s40263-019-00637-z.","journal-title":"CNS Drugs"},{"key":"1105_CR19","doi-asserted-by":"publisher","first-page":"n784","DOI":"10.1136\/bmj.n784","volume":"373","author":"M Buresh","year":"2021","unstructured":"Buresh M, Stern R, Rastegar D. Treatment of opioid use disorder in primary care. BMJ. 2021;373:n784. https:\/\/doi.org\/10.1136\/bmj.n784.","journal-title":"BMJ"},{"key":"1105_CR20","unstructured":"Durrani M, Bansal K. Methadone. In StatPearls, Treasure Island (FL): StatPearls Publishing. 2022. Accessed: 21 Sep\u00a02022. [Online]. Available:\u00a0http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562216\/."},{"issue":"15","key":"1105_CR21","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/ajhp\/zxz105","volume":"76","author":"JL Koehl","year":"2019","unstructured":"Koehl JL, Zimmerman DE, Bridgeman PJ. Medications for management of opioid use disorder. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm. 2019;76(15):1097\u2013103. https:\/\/doi.org\/10.1093\/ajhp\/zxz105.","journal-title":"Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm."},{"issue":"9","key":"1105_CR22","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.5688\/ajpe7199","volume":"83","author":"KS Murnane","year":"2019","unstructured":"Murnane KS, Augustine JM, Quesnel M, Marshall L, Strom JG. A classroom activity to increase student pharmacists confidence in dealing with the opioid epidemic. Am J Pharm Educ. 2019;83(9):7199. https:\/\/doi.org\/10.5688\/ajpe7199.","journal-title":"Am J Pharm Educ"},{"key":"1105_CR23","unstructured":"Jeanelle. Rising fentanyl use challenges current methadone induction protocols. Clin Advis.\u00a02022. https:\/\/www.clinicaladvisor.com\/home\/the-waiting-room\/fentanyl-challenges-current-methadone-induction-protocols\/ (Accessed 03 Oct\u00a02022)."},{"issue":"3","key":"1105_CR24","doi-asserted-by":"publisher","first-page":"E73","DOI":"10.1503\/cmaj.74018","volume":"192","author":"PA Randhawa","year":"2020","unstructured":"Randhawa PA, Brar R, Nolan S. Buprenorphine\u2013naloxone \u2018microdosing\u2019: an alternative induction approach for the treatment of opioid use disorder in the wake of North America\u2019s increasingly potent illicit drug market. CMAJ Can Med Assoc J. 2020;192(3):E73. https:\/\/doi.org\/10.1503\/cmaj.74018.","journal-title":"CMAJ Can Med Assoc J"},{"issue":"1","key":"1105_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/neurolint14010015","volume":"14","author":"AN Edinoff","year":"2022","unstructured":"Edinoff AN, et al. Oxytocin, a novel treatment for methamphetamine use disorder. Neurol Int. 2022;14(1):1. https:\/\/doi.org\/10.3390\/neurolint14010015.","journal-title":"Neurol Int"},{"key":"1105_CR26","unstructured":"The oxytocin receptor: from intracellular signaling to behavior | physiological reviews. https:\/\/journals.physiology.org\/doi\/full\/10.1152\/physrev.00031.2017?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org. (Accessed 21 Sep\u00a02022)."},{"issue":"5","key":"1105_CR27","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.3390\/ijms22052405","volume":"22","author":"M Sundar","year":"2021","unstructured":"Sundar M, Patel D, Young Z, Leong K-C. Oxytocin and addiction: potential glutamatergic mechanisms. Int J Mol Sci. 2021;22(5):2405. https:\/\/doi.org\/10.3390\/ijms22052405.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1105_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1113\/expphysiol.1995.sp003850","volume":"80","author":"J Russell","year":"1995","unstructured":"Russell J, Leng G, Bicknell R. Opioid tolerance and dependence in the magnocellular oxytocin system: a physiological mechanism? Exp Physiol. 1995;80(3):307\u201340. https:\/\/doi.org\/10.1113\/expphysiol.1995.sp003850.","journal-title":"Exp Physiol"},{"issue":"6","key":"1105_CR29","doi-asserted-by":"publisher","first-page":"e13025","DOI":"10.1111\/adb.13025","volume":"26","author":"X-Y Fan","year":"2021","unstructured":"Fan X-Y, Shi G, He X-J, Li X-Y, Wan Y-X, Jian L-Y. Oxytocin prevents cue-induced reinstatement of oxycodone seeking: involvement of DNA methylation in the hippocampus. Addict Biol. 2021;26(6):e13025. https:\/\/doi.org\/10.1111\/adb.13025.","journal-title":"Addict Biol"},{"issue":"12","key":"1105_CR30","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.euroneuro.2019.10.010","volume":"29","author":"X-Y Fan","year":"2019","unstructured":"Fan X-Y, Shi G, Zhao P. Methylation in Syn and Psd95 genes underlie the inhibitory effect of oxytocin on oxycodone-induced conditioned place preference. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 2019;29(12):1464\u201375. https:\/\/doi.org\/10.1016\/j.euroneuro.2019.10.010.","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"issue":"4","key":"1105_CR31","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s00213-021-05764-4","volume":"238","author":"BM Gannon","year":"2021","unstructured":"Gannon BM, Rice KC, Murnane KS. MDPV \u2018high-responder\u2019 rats also self-administer more oxycodone than their \u2018low-responder\u2019 counterparts under a fixed ratio schedule of reinforcement. Psychopharmacology. 2021;238(4):1183\u201392. https:\/\/doi.org\/10.1007\/s00213-021-05764-4.","journal-title":"Psychopharmacology"},{"issue":"4","key":"1105_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2013.285","volume":"39","author":"P Zanos","year":"2014","unstructured":"Zanos P, et al. The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice. Neuropsychopharmacology. 2014;39(4):4. https:\/\/doi.org\/10.1038\/npp.2013.285.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"1105_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/dev.21897","volume":"62","author":"KM Daigle","year":"2020","unstructured":"Daigle KM, et al. Maternal responsivity and oxytocin in opioid-dependent mothers. Dev Psychobiol. 2020;62(1):21\u201335. https:\/\/doi.org\/10.1002\/dev.21897.","journal-title":"Dev Psychobiol"},{"issue":"5","key":"1105_CR34","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1111\/j.1467-8624.1994.tb00832.x","volume":"65","author":"MK Weinberg","year":"1994","unstructured":"Weinberg MK, Tronick EZ. Beyond the face: an empirical study of infant affective configurations of facial, vocal, gestural, and regulatory behaviors. Child Dev. 1994;65(5):1503\u201315. https:\/\/doi.org\/10.1111\/j.1467-8624.1994.tb00832.x.","journal-title":"Child Dev"},{"issue":"1","key":"1105_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000496194","volume":"25","author":"M Moeini","year":"2019","unstructured":"Moeini M, Omidi A, Sehat M, Banafshe HR. The effects of oxytocin on withdrawal, craving and stress response in heroin-dependent patients: a randomized, double-blind clinical trial. Eur Addict Res. 2019;25(1):41\u20137. https:\/\/doi.org\/10.1159\/000496194.","journal-title":"Eur Addict Res"},{"issue":"13","key":"1105_CR36","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1007\/s00213-016-4308-8","volume":"233","author":"JD Woolley","year":"2016","unstructured":"Woolley JD, et al. The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study. Psychopharmacology. 2016;233(13):2571\u201380. https:\/\/doi.org\/10.1007\/s00213-016-4308-8.","journal-title":"Psychopharmacology"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-023-01105-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-023-01105-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-023-01105-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T01:17:29Z","timestamp":1682731049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-023-01105-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1105"],"URL":"https:\/\/doi.org\/10.1007\/s11916-023-01105-6","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]},"assertion":[{"value":"21 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent statement"}}]}}